We prospectively investigated the ideal imaging time to measure vascular uptake after injection of 18 F-FDG. Methods: A total of 17 patients with atherosclerotic abdominal aortic aneurysm underwent dynamic abdominal PET/CT using 2-min frames between 45 and 53, 57 and 65, 115 and 123, and 175 and 183 min after injection of 18 F-FDG. For each period of dynamic imaging, vessel wall and lumen uptake were measured using the maximum standardized uptake value (SUV max ) and target-tobackground ratio (TBR). Results: No significant difference in TBR across all time points (repeated measures ANOVA, P 5 0.206) was observed, despite a significant difference in aortic wall and lumen uptake with time (repeated measures ANOVA, P 5 0.02 and P , 0.001, respectively). There was no significant difference between aortic wall uptake at 60 min (SUV max , 2.15 6 0.11 SE) and 180 min (SUV max , 1.99 6 0.18 SE) (paired t test, P 5 0.367). There was a significant difference in lumen uptake at 60 min (SUV max , 2.4 6 0.11 SE) and 180 min (SUV max , 1.7 6 0.1 SE) (paired t test, P 5 0.001). There was no significant difference in TBR between 60 min (0.91 6 0.03) and 180 min (1.01 6 0.06 SE) (paired t test, P 5 0.131). With increasing delayed imaging, there was increasing variability (SE) in the SUV max for the aortic wall and TBRs. Conclusion: There was no significant advantage in imaging at 3 h over 1 h after 18 F-FDG injection.
PETwi th 18 F-FDG has shown potential in the imaging of atheroma inflammation and instability in both the carotid artery and aorta (1) (2) (3) (4) . This original work has progressed, and 18 F-FDG PET is being suggested for use in measuring the response to cardiovascular treatment and as a surrogate endpoint in clinical trials (5) (6) (7) (8) (9) . However, a paucity of scientific evidence regarding the technical parameters of using PET in this way exists.
One important parameter is the circulation time of 18 F-FDG. The 1-h time point is commonly used in oncology PET studies (10) . However, some have advocated performing imaging at 3 h after the injection of 18 F-FDG to maximize the contrast between plaque and background. The 3-h time point was derived from dynamic PET studies in patients with carotid disease (1) . However, this time point was based on data from a PET-only system in which physical coregistration with CT was not possible, and data were from only 8 patients. Not all investigators have used this time point (Table 1) , and more recently these same investigators have recommended at least a 90-min 18 F-FDG circulation time (8) . Therefore, there is a need for harmonization of scan parameters to enable comparison and collaboration between institutions offering vascular PET/ CT.
To address this question of the ideal circulation time of 18 F-FDG, we scanned patients with atherosclerotic abdominal aortic aneurysms. We performed PET/CT at 45, 60, 120, and 180 min after an injection of 18 F-FDG. We investigated whether there were 18 F-FDG uptake differences with time in the aortic wall and lumen of the aneurysms to determine the optimal time to image vascular inflammation using 18 F-FDG PET/CT.
MATERIALS AND METHODS

Study Population
A total of 17 consecutive asymptomatic patients (16 men, 1 woman; mean age, 74 6 5 y) undergoing routine surveillance for atherosclerotic abdominal aortic aneurysms enrolled in this prospective study. The clinical and laboratory characteristics of the study population are presented in Table 2 . A total of 9 patients had hypercholesterolemia, 10 were receiving statins, and 9 had a smoking history. No patients had any renal impairment or any features of an inflammatory aneurysm (11) . Institutional Ethics Board approval and informed consent were obtained.
Image Acquisition
All patients fasted for 6 h. After an injection of 18 F-FDG (200 MBq), we performed dynamic imaging using 2-min frames between 45 and 53, 57 and 65, 115 and 123, and 175 and 183 min with a combined PET/64-detector CT instrument (GE Healthcare). A CT scan of the patient's abdominal aorta was acquired using 64 · 3.75 mm detectors, a 1.5 pitch, and a 5-mm collimation (140 kVp and 80 mA in 0.8 s). An 18 F-FDG PET emission scan was obtained while the patient's position was maintained; the scan covered an area identical to that covered by CT. All scans were acquired in 2-dimensional mode (8 min/bed position). Transaxial emission images, 3.27 mm thick (pixel size, 3.9 mm), were reconstructed using ordered-subsets expectation maximization with 2 iterations and 28 subsets. The axial field of view was 148.75 mm, resulting in 47 slices per bed position.
Image Analysis
Coregistration and image analysis were performed using a Xeleris (GE Healthcare) workstation. PET/CT images were reviewed by a combined radiologist and nuclear medicine physician and a senior technologist in consensus. The area of most intense aortic wall 18 F-FDG uptake was identified, and regions of interest (ROIs) were drawn over the abdominal aortic wall and lumen ( Fig.  1 ). The maximum activity concentration for each region was recorded in each 2-min frame. For each period of dynamic imaging (four 2-min frames), the mean maximum activity concentration (corrected for decay) was recorded and converted to maximum standardized uptake value (SUV max ) normalized to body weight, calculated using the following formula:
ROI decay 2 corrected activity ðkBqÞ=tissue ðmLÞ; injected 18 F À FDG dose ðkBqÞ=body weight ðgÞ and the associated SE (SD/O4) was derived. This calculation was repeated in each of the 17 patients, and mean SUV max for the aortic wall and lumen and their target-to-background ratio (TBR) were derived.
Statistical Analysis
After data were examined for normality using KolmogorovSmirnov testing, ANOVA of repeated measures was used in the comparison of uptake across all the 4 time points. A paired 
2-tailed
t test was used to compare differences between variables obtained at 1 and 3 h. Statistical significance was at 5%.
RESULTS
The mean aortic wall SUV max at 45 min was 2.08, at 60 min it was 2.15, at 120 min it was 1.62, and at 180 min it was 1.99. The mean aortic lumen SUV max at 45 min was 2.30, at 60 min it was 2.40, at 120 min it was 1.74, and at 180 min it was 1.70. The mean wall-to-lumen ratio (TBR) at 45 min was 0.91, at 60 min it was 0.91, at 120 min it was 0.96, and at 190 min it was 1.01 (Table 3) .
The SDs and SEs for aortic wall SUV max and lumen SUV max and TBRs at 45, 60, 120, and 180 min after injection of 18 F-FDG are shown in Table 3 .
A significant difference in aortic wall SUV max and lumen SUV max with time (repeated measures ANOVA, P 5 0.02 and P , 0.001, respectively) and no significant difference in TBR with time (repeated measures ANOVA, P 5 0.206) were observed.
At the 2 specific time points of interest, there was no significant difference between SUV max at 60 and 180 min in the aortic wall (paired t test, P 5 0.367). There was a significant difference in SUV max in the lumen at 60 and 180 min (paired t test, P 5 0.001). There was no significant difference in TBR SUV max between 60 and 180 min (paired t test, P 5 0.131).
DISCUSSION
We conducted a study in a series of 17 patients with abdominal aortic aneurysms, which are strongly associated with both local and systemic atherosclerosis (11) , to determine the optimal time to image vascular inflammation using 18 F-FDG PET/CT. Multiple-time point PET of arterial 18 F-FDG uptake showed that delayed imaging at 3 h, compared with earlier imaging, does not significantly change the TBR. There was also no difference in aortic wall SUV max at 1 h, compared with at 3 h. Blood-pool activity as measured by lumen SUV max was significantly different at 1 and 3 h, but this did not affect the TBR.
Given that there is increasing use of 18 F-FDG uptake to assess arterial inflammation and atheroma vulnerability and to monitor the effects of pharmacologic therapies (1-9), these findings are likely to be relevant to this emerging technique. In addition, showing that there is no significant advantage of delayed imaging could favorably impact clinical practice. The prior recommended imaging time of 3 h (1) that has been implemented by others (2) could limit the feasibility in some centers of performing future screening or drug monitoring using 18 F-FDG PET. By imaging at 1 h, this should allow a better workflow for imaging departments and make the 18 F-FDG PET examination more acceptable to the patient, which is an important factor for any test.
We have also shown that the measurement of 18 F-FDG arterial wall uptake becomes more variable with delayed imaging, most probably because of the resulting decay of the tracer and the subsequent increase in image noise. Therefore, the possible benefits of delayed imaging are counterbalanced by the effects of image noise and more variable SUV max measurements. Given the relatively subtle changes involved in the imaging of atherosclerotic lesions with 18 F-FDG PET, such variability may negatively affect the findings if imaging is delayed.
Imaging at 2 h showed a decline in 18 F-FDG arterial wall uptake, a finding that was replicated in all but 6 of our patients. Although it is hard to explain such an uptake pattern, this finding could raise concern about the recommended use of imaging at 90 min (8) .
Although PET has exquisite sensitivity, it does have limited spatial resolution. Therefore, using this technique to examine the arterial wall is a challenge, and it can be difficult to accurately localize the site of uptake from PET. This is one of the reasons for choosing to examine the aorta in this study, rather than the smaller carotid arteries. The addition of CT when using a hybrid PET/CT camera for image acquisition enables the exploitation of the superior spatial resolution of CT and thus improves the anatomic certainty of the site of 18 F-FDG uptake. In particular, the use of a hybrid system helps differentiate arterial wall uptake from uptake in adjacent structures such as the lumen, which should help in the placement of ROIs and reduction of partial-volume effects. The CT used for image fusion was unenhanced; therefore, the thrombus within the sac of the aneurysm may make identification of the lumen more difficult with unenhanced CT, compared with contrast-enhanced CT. The original arterial wall uptake data suggesting that 3 h was the best imaging time (1) were acquired from the carotid arteries using a standalone PET camera, and the findings of this study may have been influenced by these factors of poor spatial resolution, partial-volume effects, and inaccurate ROI localization. There has been an inconsistent use of methodology when performing PET vascular studies (Table 1) . Different investigators have used a variety of strategies in expressing arterial 18 F-FDG uptake, including visual assessment, absolute SUV max , SUV thresholds, and TBR. Likewise, there has been a variety of imaging times used, ranging from 45 min (9,12) to 3 h. These inconsistencies probably reflect multiple factors, including habit and the demand for camera availability (13) . Therefore, as is being sought (8) , there is a need for the uniformity of methodology for arterial 18 F-FDG studies.
One recent vascular 18 F-FDG PET study did obtain dualtime point imaging data (12) . In this study, it was noted that the delayed images provided better lesion-to-background contrast during visual assessment. However, the pattern and location of 18 F-FDG uptake could be identified on both early and delayed images in all patients with significant carotid stenosis. Moreover, because the 18 F-FDG uptake on delayed images greatly decreased in the control subjects, making it difficult for ROI placement along the arterial wall, the 45-min images were used for SUV comparison.
In the current study, we performed dynamic imaging during certain time points; however, it would have been ideal to have obtained continuous dynamic images over 3 h. In practice, with elderly patients, continuous dynamic imaging may be difficult to achieve; moreover, the images would be at an increased risk of movement-induced artifacts. It would have been advantageous to have performed studies on more than the 17 patients studied. Nonetheless, such studies are time-intensive, and most of the present 18 F-FDG PET arterial studies have used similar-sized or smaller study populations (Table 1) .
CONCLUSION
Our prospective aortic wall PET data from 17 patients showed that there was no significant advantage in imaging at 3 h over 1 h after 18 F-FDG injection. Given the increasing use of vascular 18 F-FDG PET studies for risk stratification and treatment monitoring, this finding has implications for patient throughput and acceptability.
